LPAR1 and neoplasm: Furthermore, silencing Agpat4 induces lysophosphatidic acid (LPA) released from tumor cells, which subsequently promotes p38/p65 phosphorylation through LPA receptors 1 and 3, resulting in M1 polarization and inhibition of tumor progression.9